You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages

    SBC: CFD RESEARCH CORPORATION            Topic: DHA21C002

    Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Bacteriophage (phage) therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove common pyrogen contaminants from phage products, including endotoxins (lipop ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  2. Portable Phage Preparation Technology for Field Application

    SBC: CFD RESEARCH CORPORATION            Topic: A20BT023

    Bacteriophages (phages) are becoming important therapeutic candidates against multidrug resistant (MDR) bacterial infections. There is a need to isolate and concentrate phages collected from the field to enhance specimen storage stability for long-distance transport to specialized laboratories for subsequent analysis. Environmental phage preparation requires expensive, bulky instrumentation and in ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  3. N3: Negative, Nerve-Targeted Nanocarriers

    SBC: NOU SYSTEMS INC            Topic: DHA213007

    To defeat OP nerve agents, we must match both their potency and access to the synaptic cleft. Unfortunately, the most potent organophosphate antidotes cannot access neurons from the systemic circulation. Phosphotriesterase (PTE) enzyme mutants are too large, and small, cationic oximes are too charged to cross the blood-brain-barrier or blood-nerve-barrier in appreciable quantities. State-of-the-ar ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  4. Transitioning the Multiplexed Bactericidal Assay for Shigella Lipopolysaccharide Antibodies for Commercial Use

    SBC: SunFire Biotechnologies LLC            Topic: DHA202002

    In response to DHA202-002, SunFire Biotechnologies (SFB) proposed to develop a 2-fold multiplexed serum bactericidal assay (mSBA) for Shigella antibodies and to demonstrate its operational feasibility.  With that Phase I funding, SFB developed a 4-fold mSBA, based on antibiotic resistance, which allows the simultaneous testing of functional antibodies against S. flexneri serotypes 2a, 3a, and 6, ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  5. Develop and demonstrate a technology for isolation of bacteriophages with enhanced antibiofilm activity

    SBC: CFD RESEARCH CORPORATION            Topic: DHA20B003

    The twenty-first century has seen a global rise in bacterial infections exhibiting antimicrobial-resistance (AMR). More than ninety percent of chronic wounds contain microbial biofilms that exhibit AMR, and the bacteria responsible for several of these recalcitrant infections are called ESKAPEE pathogens. Eradicating ESKAPEE pathogenic infections is challenging, but bacteriophage (phage) therapy i ...

    STTR Phase II 2022 Department of DefenseDefense Health Agency
  6. Wearable Radio Frequency Weapon Exposure Detector

    SBC: ENGENIUSMICRO LLC            Topic: DHA211005

    RF weapons are an emerging battlefield threat. These directed energy weapons are being demonstrated at higher power levels and in smaller, less costly, and more mobile platforms. However, while the defense industry is just now beginning to understand the effects of high-levels of RF energy on electronic systems, through rigorous test and evaluation of instrumented targets and systems, there is sig ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  7. Dynamics for Warfighter Avatars with Complete Articulated Anatomy

    SBC: CFD RESEARCH CORPORATION            Topic: DHA17003

    Virtual human avatars will play a critical role in the next generation of advanced training environments, performance-related physiological modeling, and simulation-based design of protective armor. The overall goal of this project is to design and develop computer software for generating dynamic, mission-relevant avatar movements utilizing USARIEM’s static finite element avatars. During the ini ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  8. A Man-Portable Low Power Medical Sterilizer Using CleanSmoke™

    SBC: POLARIS SENSOR TECHNOLOGIES INC            Topic: A11AT026

    An approved high-level-disinfection-and-sterilization portable kit is developed that requires the minimum of resources to be used for a mass casualty, resource stressed field hospital scenario. The focus is on sterilization of hinged, narrow channel scope instruments, vital tools when delivering care, which can harbor organic material and bacteria. Power, time,  and staff resources pose challenge ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  9. A Human Body Model for Computational Assessment of Blast Injury and Protection

    SBC: CFD RESEARCH CORPORATION            Topic: DHP13010

    In the proposed Phase II Extension (Phase II E), we will develop and deploy a software product, Personalized CoBi-Blast and a cloud database for monitoring of repeated blast loads on Service members involved in heavy weapons training using data collected from wearable pressure sensors (blast gauges). The work in the proposed Phase II E project will focus on: • Monitoring of the repeated exposure ...

    SBIR Phase II 2021 Department of DefenseDefense Health Agency
  10. GeneCapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens

    SBC: GENECAPTURE, INC.            Topic: DHA201001

    GeneCapture proposes to develop and test an automated wound pathogen identification (ID) and Antibiotic Susceptibility Test (AST) system with strong dual-use potential in both the Military and Commercial Point-of-Care markets. The TRL6 ID test will distinguish multiple pathogens from the same sample using the company’s patented CAPTURE (Confirming Active Pathogens Through Unamplified RNA Express ...

    SBIR Phase II 2021 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government